Literature DB >> 3710859

Salivary gland malignant neoplasms: treatment and prognosis.

A Borthne, K Kjellevold, O Kaalhus, H Vermund.   

Abstract

A retrospective analysis of 183 patients with malignant salivary gland tumors treated between 1955 and 1978 is presented. The analysis showed that radiation therapy lowered the recurrence rates after surgery and controlled approximately one-third of the inoperable tumors. A dose-response relationship exists and the data suggest that the radiation dose should not be less than that corresponding to a CRE-value of 1950 reu (70 Gy/7 weeks). Histology, location and clinical stage are important prognostic factors.

Entities:  

Mesh:

Year:  1986        PMID: 3710859     DOI: 10.1016/0360-3016(86)90032-5

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  11 in total

1.  Parotid carcinoma: Current diagnostic workup and treatment.

Authors:  Vincent L M Vander Poorten; Francis Marchal; Sandra Nuyts; Paul M J Clement
Journal:  Indian J Surg Oncol       Date:  2010-11-21

2.  Carcinoma of the major salivary glands.

Authors:  S E Afify; J D Maynard
Journal:  Ann R Coll Surg Engl       Date:  1992-05       Impact factor: 1.891

3.  Carcinoma Ex Pleomorphic Adenoma Presented as a Gigantic Tumor: Treatment and Diagnostic Challenges.

Authors:  Thevagi Maruthamuthu; Jeyasakthy Saniasiaya; Irfan Mohamad; Sanjeevan Nadarajah; Norhafiza Mat Lazim; Wan Faiziah Wan Abdul Rahman
Journal:  Oman Med J       Date:  2018-07

Review 4.  Cancer of the parotid gland: role of 7th nerve preservation.

Authors:  Jeffrey D Spiro; Ronald H Spiro
Journal:  World J Surg       Date:  2003-07       Impact factor: 3.352

5.  Radiotherapy for parotid cancer.

Authors:  L M Toonkel; S Guha; P Foster; V Dembrow
Journal:  Ann Surg Oncol       Date:  1994-11       Impact factor: 5.344

6.  Clinical approach and treatment of benign and malignant parotid masses, personal experience.

Authors:  F Bussu; C Parrilla; D Rizzo; G Almadori; G Paludetti; J Galli
Journal:  Acta Otorhinolaryngol Ital       Date:  2011-06       Impact factor: 2.124

7.  A feasibility and safety study of concurrent chemotherapy based on genetic testing in patients with high-risk salivary gland tumors: Preliminary results.

Authors:  Rongrong Li; Shengjin Dou; Min Ruan; Chenping Zhang; Guopei Zhu
Journal:  Medicine (Baltimore)       Date:  2018-04       Impact factor: 1.889

8.  Adjuvant radiotherapy in malignant tumors of parotid. Experience of the Navarra Hospital Complex.

Authors:  Maitane Rodrigez Mendizábal; Sonia Flamarique Andueza; Isabel Quílez Sarda; Maider Campo; Gemma Asin Felipe; Lombardo Rosas Gutierrez; Andrea Barco Gomez; Fernando Arias de la Vega
Journal:  Rep Pract Oncol Radiother       Date:  2021-12-30

9.  Clinical history, prognostic factors, and management of facial nerve in malignant tumors of the parotid gland.

Authors:  Francesco Bussu; Mario Rigante; Veronica Giglia; Giovanni Bastanza; Eugenio De Corso; Giovanni Almadori; Gaetano Paludetti
Journal:  Clin Exp Otorhinolaryngol       Date:  2014-05-21       Impact factor: 3.372

10.  The efficacy of iodine-125 permanent brachytherapy versus intensity-modulated radiation for inoperable salivary gland malignancies: study protocol of a randomised controlled trial.

Authors:  Shu-Ming Liu; Hai-Bo Wang; Yan Sun; Yan Shi; Jie Zhang; Ming-Wei Huang; Lei Zheng; Xiao-Ming Lv; Bao-Min Zheng; Kathleen H Reilly; Xiao-Yan Yan; Ping Ji; Yang-Feng Wu; Jian-Guo Zhang
Journal:  BMC Cancer       Date:  2016-03-07       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.